Biotech drugs - revenues
This statistic shows the revenues of selected key biotech drugs in 2010. In that year, the revenue of biotech drug Rituxan was at 6.6 billion U.S. dollars.
You only have access to basic statistics.
This statistic is not included in your account.
Business Solutions including all features.
Overview
Segments
Companies
R&D, patents, new products
Outlook
Focus: COVID-19 response
Further related statistics